Business needs good ideas on lockdown
Most businesses would have seen the major challenge to the new year being the return to Level Four national lockdown and all that entailed, but they would be wrong.
How to reset goals in a crisis
Just a few short months ago, soon-to-be graduates were looking forward to celebrating commencement with their family and friends, then landing and starting their first “real job”.
Travel restrictions for South Africa as countries ban entry over Covid-19 variant
A number of countries have announced travel bans to and from South Africa, citing fears of the new Covid-19 variant discovered in the country.
Covid-19 in South Africa: Scientists seek to understand new variant
Scientists in South Africa say there is a “reasonable concern” that the new variant of Covid-19 sweeping across the country might prove to be more resistant to current vaccines being rolled out in the UK and elsewhere, and warn that it makes the need for a global roll-out of vaccines “even more critical”.
COVID-19 and the heart: What have we learned?
Early in the pandemic, epidemiologists made a striking observation. Compared to the general population, people with cardiovascular disease (CVD) were more than twice as likely to contract severe forms of COVID-19.
Study finds new evidence of SARS-CoV-2 damaging brain blood vessels
Scientists have found no trace of SARS-CoV-2 in the brains of people with the infection. However, they have observed blood vessel damage caused by the body’s inflammatory response in the post-mortem brains of patients who tested positive for the virus, which suggests the virus may indirectly attack the organ.
In Conversation: Volunteering for a COVID-19 vaccine trial
Nathan volunteered for a COVID-19 vaccine clinical trial. Lindsay is a pharmacist and the drug content integrity manager at Healthline Media. In our conversation, we discussed the realities of taking part in a vaccine clinical trial, side effects, vaccine hesitancy, and the ethics of unblinding a trial during a pandemic.
What is vaccine efficacy?
Vaccine efficacy is the percentage reduction in a disease in a group of people who received a vaccination in a clinical trial. It differs from vaccine effectiveness, which measures how well a vaccine works when given to people in the community outside of clinical trials.
Backyard schools sprout up again
THE latest stiffer Covid-19 lockdown regulations have resulted in the re-emergence of backyard schools as parents whose children barely had any meaningful lessons last year went into panic mode.
President speaks on US, congratulates Biden
President Mnangagwa has condemned the storming of the US Capitol by pro-Trump protesters on Wednesday, adding that Washington was failing to uphold the democracy it demands of other nations and that it had lost the high moral ground to punish others.








